Pemphigus treatment with azathioprine. Clinical and immunologic correlation.
D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001792:Blood Platelets; D004305:Dose-Response Relationship, Drug; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D005455:Fluorescent Antibody Technique; D006452:Hemoglobinometry; D006801:Humans; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010392:Pemphigus / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use; D011446:Prospective Studies
D000906:Antibodies; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone